Red cell volume transfused (total) · participants undergoing surgery
1 finding from 1 review
Red cell volume transfused (total) · participants undergoing surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Red cell volume transfused (total) · participants with platelet dysfunction undergoing surgery
1 finding from 1 review
30‐Day mortality · Adults and children (haemodynamically stable) with potential need for RBC transfusion
Liberal showed no clear difference in 30‐Day mortality compared with restrictive transfusion protocols (high certainty).
1 finding from 1 review
Myocardial infarction · Adults and children (haemodynamically stable) with potential need for RBC transfusion
Liberal showed no clear difference in myocardial infarction compared with restrictive transfusion protocols (high certainty).
1 finding from 1 review
Congestive heart failure · Adults and children (haemodynamically stable) with potential need for RBC transfusion
Liberal showed no clear difference in congestive heart failure compared with restrictive transfusion protocols (low certainty).
1 finding from 1 review
Stroke · Adults and children (haemodynamically stable) with potential need for RBC transfusion
Liberal showed no clear difference in cerebrovascular accident ‐ stroke compared with restrictive transfusion protocols (high certainty).
1 finding from 1 review
Rebleeding · Adults and children (haemodynamically stable) with potential need for RBC transfusion
Liberal showed no clear difference in rebleeding compared with restrictive transfusion protocols (moderate certainty).
1 finding from 1 review
Thromboembolism · Adults and children (haemodynamically stable) with potential need for RBC transfusion
Liberal showed no clear difference in thromboembolism compared with restrictive transfusion protocols (moderate certainty).
1 finding from 1 review
Infection · Adults and children (haemodynamically stable) with potential need for RBC transfusion
Liberal showed no clear difference in infection compared with restrictive transfusion protocols (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 31 to 100 days · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
It is very uncertain whether the intervention changes all‐cause mortality at 31 to 100 days (very low certainty).
1 finding from 1 review
Intervention not reported
Number of participants with any bleeding ‐ not reported · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of participants with clinically significant bleeding · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
1 finding from 1 review
Intervention not reported
Serious infections ‐ not reported · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Length of hospital admission ‐ not reported · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Hospital readmission rate ‐ not reported · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life (0 to 3 months) · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
1 finding from 1 review
Intervention not reported
Number of participants with any bleeding (0 to 3 months) · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
The intervention showed no clear difference in number of participants with any bleeding (0 to 3 months) (low certainty).
1 finding from 1 review
Intervention not reported
Number of participants with clinically significant bleeding (0 to 3 months) · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
The intervention showed no clear difference in number of participants with clinically significant bleeding (0 to 3… (low certainty).
1 finding from 1 review
Intervention not reported
Serious infections (0 to 3 months) · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
The intervention showed no clear difference in serious infections (0 to 3 months) (low certainty).
1 finding from 1 review